StockData
Alto Neuroscience, Inc. logo

Alto Neuroscience, Inc. (ANRO) stock

ANRONYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$24.91−2.21 (-8.15%)

Close on Nov 17, 2026Market cap $977.52MP/E –Yield –

Alto Neuroscience price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Alto Neuroscience's price to book ratio was 5.0× on Nov 11, 2026, against 3.4× a year earlier. Over the last 3 years it ranged from 0.4× to 5.7×, with a median of 1.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.0×+0.7
2025Dec 31, 20254.3×+3.6
2024Dec 31, 20240.7×–

More Alto Neuroscience figures

See a number that looks wrong?